openPR Logo
Press release

UMS United Medical Systems International AG: Very successful second quarter 2012 - Earnings per share up 50% to 15 cents

09-06-2012 11:35 AM CET | Health & Medicine

Press release from: UMS United Medical Systems International AG

Hamburg, August 14, 2012 - In the second quarter of 2012, UMS United Medical Systems International AG (UMS/ ISIN DE0005493654) continued its momentum from the start of the fiscal year, again increasing both revenue and earnings: Consolidated revenue increased by 18% to EUR11.1 million, up from EUR9.4 million in the previous year, while earnings per share increased by 50 percent, rising from 10 cents to 15 cents per share. Thus earnings per share grew by 29% in the first half of 2012, from 24 cents to 31 cents. Revenues increased by 16% during this period, from EUR18.6 million to EUR21.6 million.

The Urology and Radiology segments and the stable U.S. dollar were the primary sources of the significant increase in revenues. Earnings before interest and taxes (EBIT) rose by 21% in the second quarter of 2012, from EUR2.8 million last year to EUR3.4 million. Net profit after non-controlling interests increased by 36%, from EUR0.51 million in the same period last year to EUR0.70 million this year.

On the basis of the Company's solid performance in the first half, UMS AG confirms the earnings target of EUR0.60 to EUR0.70 per share for the current 2012 fiscal year. The Company intends to continue its shareholder-friendly dividend policy in 2012, provided that the exchange rate for the U.S. dollar does not weaken substantially. For fiscal years 2010 and 2011, UMS paid a dividend of 50 cents per share.

'On the basis of the very successful first half and the positive business trends in the past few weeks, we are very confident that we will reach our goals for the entire 2012 year,' says Jørgen Madsen, CEO of UMS AG.

The complete report for the second quarter of 2012 is available as a PDF file in German and English on the company's website at www.umsag.com.

About UMS AG
UMS International AG is a provider of innovative healthcare delivery concepts in the growth segment of high-tech medicine. UMS pioneered the mobile deployment of med-tech systems and markets a comprehensive range of full-service solutions for hospitals and specialists. The forward-looking concepts include complete services for the customer, covering everything from system management to the provision of trained application specialists. The UMS Group currently has over 200 employees worldwide and serves over 600 customers.

Contact
Christian Möller, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-Mail: investor@umsag.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release UMS United Medical Systems International AG: Very successful second quarter 2012 - Earnings per share up 50% to 15 cents here

News-ID: 232621 • Views:

More Releases from UMS United Medical Systems International AG

UMS AG: Satisfactory Performance in Q3 2014
- Weak US dollar continues to influence revenues and earnings - Expenses for the sale of UMS DE, Inc. adversely affect earnings per share by 19 cents or EUR0.9 million Hamburg, November 13, 2014 - UMS United Medical Systems International AG (UMS/ ISIN DE0005493654) improved its revenues and earnings in the third quarter of fiscal year 2014. Against the backdrop of a challenging market environment, the company's performance is considered satisfactory. Group
USM: Successful Closing of the Sale of United Medical Systems (DE), Inc.
Hamburg, November 11, 2014 - UMS United Medical Systems International AG (ISIN DE0005493654) has successfully consummated the sale of all shares in United Medical Systems (DE), Inc. to UMS Acquisition Holdings, Inc. (New State Capital Partners). The purchase price has been effectively transferred to the company's account today. About UMS AG UMS International AG is a provider of innovative healthcare delivery concepts in the growth segment of high-tech medicine. UMS pioneered the
Sale of all shares in United Medical Systems (DE), Inc., Massachusetts, USA
Dissemination of an Ad hoc announcement according to § 15 WpHG The issuer is solely responsible for the content of this announcement Ad-hoc-Announcement 14 August 2014 Today the Company has entered into a stock purchase agreement with UMS Acquisitions Holdings, Inc., Delaware, USA (Purchaser) regarding the sale of all shares in United Medical Systems (DE), Inc., Westborough, Massachusetts, USA, a fully owned subsidiary of the Company. The purchase price for the transfer of the
UMS AG on Track in First Half of 2014
- Exchange-rate-adjusted revenues and earnings stable - Forecast confirmed - Dividend policy unchanged Hamburg, August 14, 2014 - UMS United Medical Systems International AG (UMS/ ISIN DE0005493654) has published its figures for the first half of 2014. After an initially subdued start, business has revived, with revenues and earnings at the previous year's level when adjusted for the negative effects of the weak U.S. dollar. As a result, UMS is confirming its full-year

All 4 Releases


More Releases for EUR0

Spain Artificial Turf Market: Will Grow at a CAGR of 8.4%, Highest Revenue Growt …
Artificial turf is a composite consisting of man-crafted, organic, grassy fibers. The blades are green and are usable in different stack heights. This is designed in the same fashion as a tapet, and it has a strong back, and the blades are stitched on by a machine. The majority of the new grass developed today often weaves into a brown stalk which resembles the appearance of dead grass one sees
Spain Artificial Turf Market--Will Grow at a CAGR of 8.4%, Highest Revenue Growt …
By focusing on all the necessities and requirements of the businesses for achieving a successful business growth, the supreme Spain Artificial Turf report is generated. The CAGR values estimate the fluctuation about the rise or fall of demand for the specific forecasted period with respect to investment. This business report also recognizes and analyses the expanding trends along with major drivers, restraints, challenges and opportunities in the market. This is